academic article

• 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery..  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology.  21:287-293. 2011
• Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM)..  European psychiatry : the journal of the Association of European Psychiatrists.  25:338-344. 2010
• Comparison of olanzapine and risperidone in the EMBLEM Study: translation of randomized controlled trial findings into clinical practice..  International clinical psychopharmacology.  25:257-263. 2010
• Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM)..  Journal of affective disorders.  118:118-123. 2009
• Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study..  Pharmacopsychiatry.  42:145-152. 2009
• Stability and treatment outcome of distinct classes of mania..  European psychiatry : the journal of the Association of European Psychiatrists.  23:360-367. 2008
• Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study..  Actas españolas de psiquiatría.  35:315-322. 2007
• Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes..  Current medical research and opinion.  22:961-966. 2006
• Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status..  International clinical psychopharmacology.  17:227-237. 2002